CHI Announces Next-Generation Sequencing in Molecular Pathology Short Course

NEEDHAM, Mass. - Dec. 19, 2013 - PRLog -- Cambridge Healthtech Institute announces its Next-Generation Sequencing in Molecular Pathology: Challenges and Applications short course, which will take place at the Moscone North Convention Center in San Francisco, CA on February 10, 2014 from 8:30-11:30 AM.  Co-organized with the College of American Pathologists (CAP), this short course will cover the following topics:

• Technology and Interpretation of Next Generation Sequencing
• Development of Laboratory Standards for Next-Generation Sequencing as a Clinical Tool

Instructors:

• Wayne Grody, M.D., Ph.D., FCAP, FACMG, Professor, Departments of Pathology & Laboratory Medicine, Pediatrics, and Human Genetics at the UCLA School of Medicine.

• Karl Voelkerding, M.D., Professor, Pathology, University of Utah; Medical Director, Genomics and Bioinformatics, ARUP Laboratories.

• Nazneen Aziz, Ph.D., Director of Molecular Medicine, Transformation Program Office, College of American Pathologists

For more information on this short course and to register, visit http://bit.ly/1gIVTT9

About Cambridge Healthtech Institute (http://www.healthtech.com)

CHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and CHI's Media Group, which includes news websites and e-newsletters including Bio-IT World and Clinical Informatics News.

About Molecular Med Tri-Conference (http://www.triconference.com)

The 21st International Molecular Medicine Tri-Conference is the industry's Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology. Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, over 20 short courses, and 15 main programs. For the first time in over 10 years we're bringing back a dedicated conference on sequencing. As many will recall this event's infancy was heavily devoted to the Human Genome Project and we are excited to reintroduce sequencing to this event.